Log In
Print this Print this

Proteasome inhibitors

  Manage Alerts
Collapse Summary General Information
Company Cytomics Pharmaceuticals
DescriptionNon-catalytic inhibitors of proteasome targeting the regulatory subunit of the proteasome
Molecular Target Proteasome
Mechanism of ActionProteasome inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today